Literature DB >> 7605510

Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis.

G Taliani, F Duca, R Lecce, D Livoli, C Pasquazzi, C De Bac.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7605510

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Does Hepatic Steatosis Influence the Virological Response with Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir Disoproxil Fumarate?

Authors:  Roni Atalay; Süleyman Sayar; Fatma Gülçiçek Ayrancı; Şüheda Çakmak; İbrahim Halil Tanboğa; Levent Doğanay; Kamil Özdil
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

2.  Even 'safe' medications need to be administered with care.

Authors:  Nancy Lutwak; Mary Ann Howland; Rosemarie Gambetta; Curt Dill
Journal:  BMJ Case Rep       Date:  2013-01-02

3.  Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.

Authors:  Xi Jin; Yi-peng Chen; Yi-da Yang; You-ming Li; Lin Zheng; Chuan-qing Xu
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

4.  Comparison of first-year results of tenofovir and entecavir treatments of nucleos(t)ide-naive chronic hepatitis B patients with hepatosteatosis.

Authors:  Zeynal Dogan; Levent Filik; Bilal Ergül; Murat Sarikaya
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.